EGFR and head and neck squamous cell carcinoma: The analysis of EpCAM expression in combination with the expression of the epidermal growth factor receptor (EGFR), which is a therapeutic target in HNSCC, further disclosed that high expression of EGFR and low expression of EpCAM correlated with very poor survival.